Top 10 Dapagliflozin (Farxiga) Generic Manufacturers in Israel

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Israel is experiencing significant growth, with a strong focus on the production of generic medications such as Dapagliflozin (Farxiga). The country has established itself as a key player in the global pharmaceutical market, with a growing number of top manufacturers producing high-quality generic drugs. In fact, Israel is among the top countries in the world for generic drug production, with a high production volume and a strong presence in the international market.

Top 10 Dapagliflozin (Farxiga) Generic Manufacturers in Israel:

1. Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is the leading generic drug manufacturer in Israel, with a production volume of over 80% of the country’s total generic drug output. The company has a strong presence in the global market and is known for its high-quality products.

2. Perrigo Company
Perrigo Company is another major player in the Israeli pharmaceutical industry, with a significant market share in the production of generic medications. The company has a diverse portfolio of products, including Dapagliflozin (Farxiga) generics.

3. Mylan Pharmaceuticals
Mylan Pharmaceuticals is a key player in the Israeli pharmaceutical market, with a focus on producing affordable generic drugs. The company has a strong presence in the production of Dapagliflozin (Farxiga) generics and is known for its high-quality products.

4. Rafa Laboratories
Rafa Laboratories is a well-established pharmaceutical company in Israel, with a strong focus on producing generic medications. The company has a significant market share in the production of Dapagliflozin (Farxiga) generics and is known for its innovative products.

5. Neopharm Group
Neopharm Group is a leading pharmaceutical company in Israel, with a diverse portfolio of generic medications. The company has a strong presence in the production of Dapagliflozin (Farxiga) generics and is known for its commitment to quality.

6. Taro Pharmaceuticals
Taro Pharmaceuticals is a major player in the Israeli pharmaceutical industry, with a focus on producing high-quality generic medications. The company has a significant market share in the production of Dapagliflozin (Farxiga) generics and is known for its innovative products.

7. Trima Pharmaceuticals
Trima Pharmaceuticals is a key player in the Israeli pharmaceutical market, with a strong focus on producing affordable generic drugs. The company has a significant market share in the production of Dapagliflozin (Farxiga) generics and is known for its high-quality products.

8. Unipharm
Unipharm is a well-established pharmaceutical company in Israel, with a diverse portfolio of generic medications. The company has a strong presence in the production of Dapagliflozin (Farxiga) generics and is known for its commitment to quality.

9. Dexcel Pharma
Dexcel Pharma is a leading pharmaceutical company in Israel, with a focus on producing high-quality generic medications. The company has a significant market share in the production of Dapagliflozin (Farxiga) generics and is known for its innovative products.

10. Sigmapharm Laboratories
Sigmapharm Laboratories is a major player in the Israeli pharmaceutical industry, with a focus on producing affordable generic medications. The company has a significant market share in the production of Dapagliflozin (Farxiga) generics and is known for its high-quality products.

Insights:

The pharmaceutical industry in Israel is expected to continue its growth trajectory, with a focus on producing high-quality generic medications such as Dapagliflozin (Farxiga) generics. The country’s top manufacturers are well-positioned to capitalize on this trend, with a strong presence in the international market and a commitment to innovation. As the demand for generic drugs continues to rise globally, Israel’s pharmaceutical industry is poised to play an increasingly important role in meeting this demand.

Overall, the market for Dapagliflozin (Farxiga) generics in Israel is expected to experience steady growth in the coming years, with a focus on quality and affordability driving the industry forward. With a strong base of top manufacturers producing high-quality generic medications, Israel is well-positioned to continue its success in the global pharmaceutical market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →